Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 3/20 | 0.39 |
| ▸ | CNR2 | P34972 | 3/20 | 0.39 |
| ▸ | C3AR1 | Q16581 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2913040 | 0.93 | TSHR (0.44) | TSHRCYP3A4C3AR1SMN1; SMN2GAA | |
| SCHEMBL2915021 | 0.87 | KCNH2 (0.44) | TSHRCYP3A4KCNH2NR1H4SMN1; SMN2 | |
| SCHEMBL2907592 | 0.86 | NPC1 (0.42) | TSHRCYP3A4KCNH2NR1H4CNR1 | |
| SCHEMBL2906901 | 0.82 | CNR1 (0.40) | TSHRCYP3A4KCNH2NR1H4CNR1 | |
| SCHEMBL2909615 | 0.82 | C3AR1 (0.43) | TSHRCYP3A4C3AR1SMN1; SMN2CYP2C19 | |
| SCHEMBL2907586 | 0.81 | EPHX1 (0.41) | TSHRCYP3A4KCNH2NR1H4SMN1; SMN2 | |
| SCHEMBL2912405 | 0.81 | ALDH1A1 (0.40) | TSHRCYP3A4KCNH2NR1H4CNR1 | |
| SCHEMBL2910028 | 0.80 | SMN1; SMN2 (0.45) | TSHRCYP3A4C3AR1SMN1; SMN2GAA | |
| SCHEMBL2915028 | 0.79 | KMT2A (0.43) | C3AR1SMN1; SMN2GAANPC1RAB9A | |
| SCHEMBL3651303 | 0.78 | CYP3A4 (0.38) | TSHRCYP3A4KCNH2NR1H4CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2222645-A2 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS | F. Hoffmann-La Roche AG (CH) | 2010-09-01 | — | — | EP | claimed |
| WO-2009062874-A2 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-05-22 | — | — | WO | claimed |
| EP-2222645-A2 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS | F. Hoffmann-La Roche AG (CH) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009062874-A2 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-05-22 | — | — | WO | disclosed |